Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.26
Delayed Data
As of Feb 17
 -0.01 / -0.44%
Today’s Change
2.05
Today|||52-Week Range
4.80
-1.74%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.27
Today’s open2.27
Day’s range2.25 - 2.30
Volume31,051
Average volume (3 months)74,042
Market cap$25.0M
Dividend yield--
Data as of 3:58pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+47.37%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.67%
P/E ratioNM
Price/Sales1.80
Price/Book0.46

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.07-2.61%
APRIApricus Biosciences ...+0.32+10.94%
HTBXHeat Biologics Inc-0.03-2.77%
CATBCatabasis Pharmaceut...0.000.00%
Data as of 4:00pm ET, 02/17/2017

Financials

Last reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$21.0M
Annual profit (last year)-$9.2M
Net profit margin-44.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs